Lipella Pharma (LIPO): Wutah pendapatan kuartal marang kuartal

Logo perusahaan publik lipella.com (LIPO)

The quarterly sales growth rate illustrates revenue dynamics, with the latest figure standing at -11.40. This chart complements the strategy of Lipella Pharmaceuticals (LIPO) to develop targeted drug delivery systems for urology. The company minimizes risks through a diverse oncology pipeline, focusing on untapped market niches with high demand potential upon the successful completion of trials.

LIPO (Lipella) riwayat Tingkat wutah pendapatan sajrone kuartal saka 28.04.2023 nganti 19.07.2025

Lipella Pharmaceuticals, Inc. - rincian analitis lan metrik utama (LIPO)

- rega saham lan target rega konsensus:
- informasi babagan dhuwit lan arus kas:
Analisis kabeh metrik perusahaan:Lipella Pharmaceuticals - LIPO
Produk seri lipella.com

For Lipella Pharmaceuticals (LIPO), whose resilience is limited by a dependence on a single drug and the risk of clinical trial failure, the pace of capital inflows becomes a critical survival marker. By analyzing this quarterly revenue chart, an investor assesses the speed of business expansion relative to the previous quarter, allowing them to detect stagnation in time and avoid overpaying for the asset at the peak of its short-term acceleration.

Perusahaan pesaing

HLN - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal kenvue.com|Verona Pharma (VRNA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Amneal Pharmaceuticals Inc AMRX|Wutah pendapatan triwulanan PRGO|Owah-owahan dodolan kuartal marang kuartal ALVO|Wutah pendapatan triwulanan LQDA (Liquidia Technologies)|Wutah pendapatan triwulanan Galapagos GLPG|ANI Pharmaceuticals Inc - Wutah pendapatan triwulanan|MNKD (MannKind Corp.) - Wutah dodolan kuartal marang kuartal|AMPH: Wutah pendapatan triwulanan|PCRX (Pacira BioSciences) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal ARS Pharmaceuticals Inc|Wutah dodolan triwulanan Theravance Biopharma, Inc. (TBPH)|Wutah dodolan triwulanan AQST (Aquestive Pharma)|SCPH - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan TECX (Tectonic Therapeutic, Inc.)|TNXP - Wutah dodolan triwulanan|China SXT Pharmaceuticals, Inc. - Wutah pendapatan triwulanan|EPRX - Wutah pendapatan triwulanan|BHST: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ENTX (Entera Bio)|Wutah pendapatan kuartal marang kuartal MindWalk (HYFT)|Wutah pendapatan triwulanan ABVC BioPharma, Inc. (ABVC)|Wutah pendapatan kuartal marang kuartal Cumberland Corp CPIX|QNTM - Wutah dodolan triwulanan|FGEN - Wutah pendapatan kuartal marang kuartal|TELO - Wutah pendapatan triwulanan|Rani Therapeutics Inc (RANI) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal SNYR|Wutah pendapatan kuartal marang kuartal Rallybio Corp|Wutah pendapatan kuartal marang kuartal LEXX|Wutah pendapatan triwulanan PULM|PTHL: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan triwulanan APM (Aptorum Group Ltd)|LYRA - Wutah dodolan triwulanan|Impact BioMedical Inc - Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal TNFA|YCBD (cbdmd.com) - Wutah dodolan triwulanan|painreform.com - Tambahing pendapatan triwulanan|Wutah dodolan triwulanan CYTO|OPTN: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Pieris (PIRS)|Wutah pendapatan triwulanan Procaps Group Corp (PROC)|Wutah pendapatan triwulanan PTPI (petrospharma.com)|Tambahing pendapatan triwulanan QLI|ACELYRIN - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan TFFP (TFF Pharmaceuticals Inc.)